查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1362867

HIV 診斷市場規模、佔有率、趨勢分析報告：按產品、測試類型、模式、最終用途、地區和細分市場預測，2023-2030 年

HIV Diagnostics Market Size, Share & Trends Analysis Report By Product (Consumables, Instruments), By Test Type (Antibody Tests, Viral Load Tests), By Mode (Self-Test, Lab-based), By End-use, By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

HIV診斷市場的成長和趨勢

Grand View Research, Inc. 的一項新研究顯示，到 2030 年，全球愛滋病毒診斷市場預計將達到 15.5017 億美元，2023 年至 2030 年年複合成長率預計為 5.5%。這一市場成長的主要要素包括開發更靈敏的 HIV 診斷 POC 測試的需求不斷成長，這些測試可以在資源有限的環境中輕鬆地在患者照護端進行。在預測期內，檢測技術的開拓以及預計推出的大量新型快速POC檢測將是推動HIV診斷市場成長的主要要素。此外，政府針對愛滋病毒發起的計劃和運動、全球為減少疾病罹患率而開展的醫療保健配合措施、中東和東部地區市場存在的大量未滿足的需求都將有利於未來的成長機會。以下是一些預計會發揮作用的關鍵因素。

HIV 診斷市場報告亮點

  • 抗體測試類型在產業中佔據主導地位，2022年佔最大收益佔有率為53.3%。如此大的佔有率可以解釋為這些測試的高市場使用率和普及，包括 ELISA、家庭訪問乾血斑、蛋白質印跡測試 IFA 和 RIPA。由於這些檢測靈敏且準確，因此最常用於篩檢和確認 HIV-1 和 HIV-2。
  • 病毒負擔測試和 CD4 測試也將在 2022 年佔據相當大的市場。這些檢測更加靈敏、快速，並且可以攜帶到照護端，從而提高了其市場效用和資源匱乏的愛滋病毒感染地區的可及性。
  • 在預測期內，目前正在臨床開發和主要市場參與者的產品平臺中的許多新型即時愛滋病毒診斷產品預計將實現商業化。預計此類產品的增加將在預測期內推動同一市場的成長。
  • 亞太地區佔據市場主導地位，2022 年佔最大銷售佔有率，達 35.7%。這是由於技術的進步、受愛滋病毒/愛滋病罹患的人數增加以及該地區對愛滋病毒/愛滋病認知的提高。
  • 由於該地區診斷測試意識不斷增強，預計拉丁美洲在預測期內將以 6.9% 的年複合成長率成長最快。

目錄

第1章 調查方法與範圍

第2章 執行摘要

第3章 HIV 診斷市場變數、趨勢、範圍

  • 市場體系預測
    • 母市場預測
    • 相關/附隨市場預測
  • 普及和成長預測圖
  • 市場動態
    • 市場促進因素分析
    • 市場抑制因素分析
  • HIV 診斷市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第4章 HIV 診斷市場：產品評估與趨勢分析

  • HIV診斷市場的要點
  • HIV 診斷市場：2022 年和 2030 年趨勢和市場佔有率分析
  • 消耗品
  • 裝置
  • 軟體和服務

第5章 HIV 診斷市場：模式估計與趨勢分析

  • HIV診斷市場的要點
  • HIV 診斷市場：2022 年和 2030 年趨勢和市場佔有率分析
  • 自我測試
  • 實驗室基地

第6章 HIV 診斷市場：測試類型估計和趨勢分析

  • HIV診斷市場的要點
  • HIV 診斷市場：2022 年和 2030 年趨勢和市場佔有率分析
  • 抗體測試
  • 病毒負擔測試
  • CD4測試
  • 其他

第7章 HIV 診斷市場：最終用途估計與趨勢分析

  • HIV 診斷市場：要點
  • HIV 診斷市場：2022 年和 2030 年趨勢和市場佔有率分析
  • 診斷實驗室
  • 醫院和診所
  • 居家環境
  • 其他

第8章 HIV 診斷市場：區域估計與趨勢分析

  • 區域預測
  • 按地區分類的愛滋病毒診斷市場：市場要點
  • 北美洲
    • 2018-2030 年市場估計與預測
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 瑞典
    • 挪威
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 泰國
    • 韓國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東/非洲
    • 沙烏地阿拉伯
    • 南非
    • 阿拉伯聯合大公國
    • 科威特

第9章 競爭形勢

  • 主要市場參與企業的最新趨勢和影響分析
  • 市場參與企業分類
    • Alere Inc.
    • Abbott.
    • Bristol-Myers Squibb Company
    • Janssen Global Service, LLC
    • Gilead Sciences, Inc.
    • Merck & Co. Inc.
    • VIIV Healthcare
    • BD
    • Beckman Coulter, Inc.
    • Sysmex Europe SE
    • Apogee Flow Systems
    • Point Care Technologies Inc.
    • Mylan NV
    • F. Hoffman-La Roche Ltd.
    • Siemens Healthcare GmbH
    • QIAGEN.
Product Code: 978-1-68038-461-1

HIV Diagnostics Market Size Growth & Trends:

The global HIV diagnostics market is expected to reach USD 1550.17 million by 2030, growing at an estimated CAGR of 5.5% from 2023 to 2030, according to a new study by Grand View Research, Inc.. Key factors accounting for the growth of this market include the growing need in for the development of more sensitive HIV diagnostic point of care tests which can be easily implemented at the location of patient care in resource-limited settings. Technological development of tests which is expected to introduce a number of novel rapid, point-of-care tests throughout the forecast period is a primary factor expected to fuel the growth of the HIV diagnostics market. Furthermore, government programs and campaigns initiated against HIV, global healthcare efforts to reduce disease incidence, and the presence of high unmet demand in the Middle Eastern and Eastern regions of the market are some key factors expected to serve as lucrative future growth opportunities.

HIV Diagnostics Market Report Highlights:

  • The antibody test type segment dominated the industry and accounted for the largest revenue share of 53.3% in 2022. This large share can be accounted for by the high market usage and penetration rates of these tests which include, ELISA, home access dried blood spot, western blot testing IFA, and RIPA. These tests are highly sensitive and accurate and thus are most commonly used for screening and confirmation of HIV-1 & HIV-2.
  • Viral Load testing and CD4 testing also accounted for a considerable share of the market in 2022. There is a prevalent in the market for the development of these tests which will make them more sensitive, rapid in nature, and portable to the point of care to enhance their market usability and accessibility in resource-limited HIV-affected regions.
  • It is expected that during the forecast period, a number of novel point-of-care HIV diagnostic products will be commercialized which are currently under clinical development and in product pipelines of key market players. This increase in the range of products is expected to fuel the growth of this market over the forecast period.
  • Asia Pacific dominated the market and accounted for the largest revenue share of 35.7% in 2022 owing to technological advancement, an increase in the number of people suffering from HIV and AIDS, and increasing awareness regarding the same in this region.
  • Latin America is expected to grow at the fastest CAGR of 6.9% during the forecast period owing to the increasing awareness about diagnostic testing in the region.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Product
    • 1.1.2. Mode
    • 1.1.3. Test type
    • 1.1.4. End-use
    • 1.1.5. Regional scope
    • 1.1.6. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Mode outlook
    • 2.2.3. Test type
    • 2.2.4. End-use outlook
    • 2.2.5. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. HIV Diagnostics Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market Driver Analysis
    • 3.3.2. Market Restraint Analysis
  • 3.4. HIV Diagnostics Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic Landscape

Chapter 4. HIV Diagnostics Market: Product Estimates & Trend Analysis

  • 4.1. HIV Diagnostics Market Key Takeaways
  • 4.2. HIV Diagnostics Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Consumables
    • 4.3.1. Consumables market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. Instruments
    • 4.4.1. Instruments test market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. Software And Services
    • 4.5.1. Software and services market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. HIV Diagnostics Market: Mode Estimates & Trend Analysis

  • 5.1. HIV Diagnostics Market Key Takeaways
  • 5.2. HIV Diagnostics Market: Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Self-Test
    • 5.3.1. Self-test market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.4. Lab-Based
    • 5.4.1. Lab-based market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. HIV Diagnostics Market: Test Type Estimates & Trend Analysis

  • 6.1. HIV Diagnostics Market Key Takeaways
  • 6.2. HIV Diagnostics Market: Movement & Market Share Analysis, 2022 & 2030
  • 6.3. Antibody Test
    • 6.3.1. Antibody test market estimates and forecasts, 2018 to 2030 (USD Million)
      • 6.3.1.1. HIV -1 screening market estimates and forecasts, 2018 to 2030 (USD Million)
      • 6.3.1.1.1. ELISA/EIA market estimates and forecasts, 2018 to 2030 (USD Million)
      • 6.3.1.1.2. Home access dried blood spot market estimates and forecasts, 2018 to 2030 (USD Million)
      • 6.3.1.1.3. Rapid tests (Dot plot, Agglutination tests) market estimates and forecasts, 2018 to 2030 (USD Million)
      • 6.3.1.2. HIV-1 antibody confirmatory tests
      • 6.3.1.2.1. Western blot test market estimates and forecasts, 2018 to 2030 (USD Million)
      • 6.3.1.2.2. Indirect Immunofluorescent Antibody Assay (IFA) market estimates and forecasts, 2018 to 2030 (USD Million)
      • 6.3.1.2.3. Line immunoassay market estimates and forecasts, 2018 to 2030 (USD Million)
      • 6.3.1.2.4. RadioImmunoPrecipitation Assay (RIPA) market estimates and forecasts, 2018 to 2030 (USD Million)
      • 6.3.1.3. HIV-2 and group O diagnostic tests
      • 6.3.1.3.1. Blood antibody tests market estimates and forecasts, 2018 to 2030 (USD Million)
      • 6.3.1.3.2. Dried Blood Spot (DBS) test market estimates and forecasts, 2018 to 2030 (USD Million)
      • 6.3.1.3.3. Others (Oral, Urine) market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.4. Viral Load Test
    • 6.4.1. Viral load test market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.5. CD4 Test
    • 6.5.1. CD4 test market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.6. Others
    • 6.6.1. Other market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. HIV Diagnostics Market: End-use Estimates & Trend Analysis

  • 7.1. HIV Diagnostics Market: Key Takeaways
  • 7.2. HIV Diagnostics Market: Movement & Market Share Analysis, 2022 & 2030
  • 7.3. Diagnostic Laboratories
    • 7.3.1. Diagnostic laboratories market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.4. Hospitals & Clinics
    • 7.4.1. Hospitals & Clinics Market Estimates and Forecasts, 2018 to 2030 (USD Million)
  • 7.5. Home Settings
    • 7.5.1. Home settings market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.6. Others
    • 7.6.1. Other market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 8. HIV Diagnostics Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Outlook
  • 8.2. HIV Diagnostics Market by Region: Key Marketplace Takeaway
  • 8.3. North America
    • 8.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.3.2. U.S.
      • 8.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.3.3. Canada
      • 8.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 8.4. Europe
    • 8.4.1. UK
      • 8.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.4.2. Germany
      • 8.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.4.3. France
      • 8.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.4.4. Italy
      • 8.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.4.5. Spain
      • 8.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.4.6. Sweden
      • 8.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.4.7. Norway
      • 8.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.4.8. Denmark
      • 8.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 8.5. Asia Pacific
    • 8.5.1. Japan
      • 8.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.5.2. China
      • 8.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.5.3. India
      • 8.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.5.4. Australia
      • 8.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.5.5. Thailand
      • 8.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.5.6. South Korea
      • 8.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 8.6. Latin America
    • 8.6.1. Brazil
      • 8.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.6.2. Mexico
      • 8.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.6.3. Argentina
      • 8.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 8.7. MEA
    • 8.7.1. Saudi Arabia
      • 8.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.7.2. South Africa
      • 8.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.7.3. UAE
      • 8.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.7.4. Kuwait
      • 8.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 9.2. Market Participant Categorization
    • 9.2.1. Alere Inc.
      • 9.2.1.1. Company overview
      • 9.2.1.2. Financial performance
      • 9.2.1.3. Product benchmarking
      • 9.2.1.4. Strategic initiatives
    • 9.2.2. Abbott.
      • 9.2.2.1. Company overview
      • 9.2.2.2. Financial performance
      • 9.2.2.3. Product benchmarking
      • 9.2.2.4. Strategic initiatives
    • 9.2.3. Bristol-Myers Squibb Company
      • 9.2.3.1. Company overview
      • 9.2.3.2. Financial performance
      • 9.2.3.3. Product benchmarking
      • 9.2.3.4. Strategic initiatives
    • 9.2.4. Janssen Global Service, LLC
      • 9.2.4.1. Company overview
      • 9.2.4.2. Financial performance
      • 9.2.4.3. Product benchmarking
      • 9.2.4.4. Strategic initiatives
    • 9.2.5. Gilead Sciences, Inc.
      • 9.2.5.1. Company overview
      • 9.2.5.2. Financial performance
      • 9.2.5.3. Product benchmarking
      • 9.2.5.4. Strategic initiatives
    • 9.2.6. Merck & Co. Inc.
      • 9.2.6.1. Company overview
      • 9.2.6.2. Financial performance
      • 9.2.6.3. Product benchmarking
      • 9.2.6.4. Strategic initiatives
    • 9.2.7. VIIV Healthcare
      • 9.2.7.1. Company overview
      • 9.2.7.2. Financial performance
      • 9.2.7.3. Product benchmarking
      • 9.2.7.4. Strategic initiatives
    • 9.2.8. BD
      • 9.2.8.1. Company overview
      • 9.2.8.2. Financial performance
      • 9.2.8.3. Product benchmarking
      • 9.2.8.4. Strategic initiatives
    • 9.2.9. Beckman Coulter, Inc.
      • 9.2.9.1. Company overview
      • 9.2.9.2. Financial performance
      • 9.2.9.3. Product benchmarking
      • 9.2.9.4. Strategic initiatives
    • 9.2.10. Sysmex Europe SE
      • 9.2.10.1. Company overview
      • 9.2.10.2. Financial performance
      • 9.2.10.3. Product benchmarking
      • 9.2.10.4. Strategic initiatives
    • 9.2.11. Apogee Flow Systems
      • 9.2.11.1. Company overview
      • 9.2.11.2. Financial performance
      • 9.2.11.3. Product benchmarking
      • 9.2.11.4. Strategic initiatives
    • 9.2.12. Point Care Technologies Inc.
      • 9.2.12.1. Company overview
      • 9.2.12.2. Financial performance
      • 9.2.12.3. Product benchmarking
      • 9.2.12.4. Strategic initiatives
    • 9.2.13. Mylan N.V.
      • 9.2.13.1. Company overview
      • 9.2.13.2. Financial performance
      • 9.2.13.3. Product benchmarking
      • 9.2.13.4. Strategic initiatives
    • 9.2.14. F. Hoffman-La Roche Ltd.
      • 9.2.14.1. Company overview
      • 9.2.14.2. Financial performance
      • 9.2.14.3. Product benchmarking
      • 9.2.14.4. Strategic initiatives
    • 9.2.15. Siemens Healthcare GmbH
      • 9.2.15.1. Company overview
      • 9.2.15.2. Financial performance
      • 9.2.15.3. Product benchmarking
      • 9.2.15.4. Strategic initiatives
    • 9.2.16. QIAGEN.
      • 9.2.16.1. Company overview
      • 9.2.16.2. Financial performance
      • 9.2.16.3. Product benchmarking
      • 9.2.16.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 North America HIV diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 3 North America HIV diagnostics market by mode, 2018 - 2030 (USD Million)
  • Table 4 North America HIV diagnostics Market by test type, 2018 - 2030 (USD Million)
  • Table 5 North America HIV diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 6 North America HIV diagnostics market by region, 2018 - 2030 (USD Million)
  • Table 7 U.S. HIV diagnostics Market by product, 2018 - 2030 (USD Million)
  • Table 8 U.S. HIV diagnostics market by mode, 2018 - 2030 (USD Million)
  • Table 9 U.S. HIV diagnostics Market by test type, 2018 - 2030 (USD Million)
  • Table 10 U.S. HIV diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 11 Canada HIV diagnostics market by product, 2018 - 2030 (USD Million)
  • Table 12 Canada HIV diagnostics market by mode, 2018 - 2030 (USD Million)
  • Table 13 Canada. HIV diagnostics market by test type, 2018 - 2030 (USD Million)
  • Table 14 Canada HIV diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 15 Europe HIV diagnostics market by product, 2018 - 2030 (USD Million)
  • Table 16 Europe HIV diagnostics market by mode, 2018 - 2030 (USD Million)
  • Table 17 Europe HIV diagnostics market by test type, 2018 - 2030 (USD Million)
  • Table 18 Europe HIV diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 19 Europe HIV diagnostics market, by region, 2018 - 2030 (USD Million)
  • Table 20 Germany HIV diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 21 Germany HIV diagnostics market, by mode, 2018 - 2030 (USD Million)
  • Table 22 Germany HIV diagnostics market by test type, 2018 - 2030 (USD Million)
  • Table 23 Germany HIV diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 24 UK HIV diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 25 UK HIV diagnostics market, by mode, 2018 - 2030 (USD Million)
  • Table 26 UK HIV diagnostics market by test type, 2018 - 2030 (USD Million)
  • Table 27 UK HIV diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 28 France HIV diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 29 France HIV diagnostics market, by mode, 2018 - 2030 (USD Million)
  • Table 30 France HIV diagnostics market by test type, 2018 - 2030 (USD Million)
  • Table 31 France HIV diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 32 Italy HIV diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 33 Italy HIV diagnostics market, by mode, 2018 - 2030 (USD Million)
  • Table 34 Italy HIV diagnostics market by test type, 2018 - 2030 (USD Million)
  • Table 35 Italy HIV diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 36 Spain HIV diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 37 Spain HIV diagnostics market, by mode, 2018 - 2030 (USD Million)
  • Table 38 Spain HIV diagnostics market by test type, 2018 - 2030 (USD Million)
  • Table 39 Spain HIV diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 40 Sweden HIV diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 41 Sweden HIV diagnostics market, by mode, 2018 - 2030 (USD Million)
  • Table 42 Sweden HIV diagnostics market by test type, 2018 - 2030 (USD Million)
  • Table 43 Sweden HIV diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 44 Norway HIV diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 45 Norway HIV diagnostics market, by mode, 2018 - 2030 (USD Million)
  • Table 46 Norway HIV diagnostics market by test type, 2018 - 2030 (USD Million)
  • Table 47 Norway HIV diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 48 Denmark HIV diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 49 Denmark HIV diagnostics market, by mode, 2018 - 2030 (USD Million)
  • Table 50 Denmark HIV diagnostics market by test type, 2018 - 2030 (USD Million)
  • Table 51 Denmark HIV diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 52 Asia Pacific HIV diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 53 Asia Pacific HIV diagnostics market, by mode, 2018 - 2030 (USD Million)
  • Table 54 Asia Pacific HIV diagnostics market by test type, 2018 - 2030 (USD Million)
  • Table 55 Asia Pacific HIV diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 56 Asia Pacific HIV diagnostics market, by region, 2018 - 2030 (USD Million)
  • Table 57 China HIV diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 58 China HIV diagnostics market, by mode, 2018 - 2030 (USD Million)
  • Table 59 China. HIV diagnostics market by test type, 2018 - 2030 (USD Million)
  • Table 60 China HIV diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 61 Japan HIV diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 62 Japan HIV diagnostics market, by mode, 2018 - 2030 (USD Million)
  • Table 63 Japan HIV diagnostics market by test type, 2018 - 2030 (USD Million)
  • Table 64 Japan HIV diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 65 India HIV diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 66 India HIV diagnostics market, by mode, 2018 - 2030 (USD Million)
  • Table 67 India HIV diagnostics market by test type, 2018 - 2030 (USD Million)
  • Table 68 India HIV diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 69 Australia HIV diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 70 Australia HIV diagnostics market, by mode, 2018 - 2030 (USD Million)
  • Table 71 Australia HIV diagnostics market by test type, 2018 - 2030 (USD Million)
  • Table 72 Australia HIV diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 73 Thailand HIV diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 74 Thailand HIV diagnostics market, by mode, 2018 - 2030 (USD Million)
  • Table 75 Thailand HIV diagnostics market by test type, 2018 - 2030 (USD Million)
  • Table 76 Thailand HIV diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 77 South Korea HIV diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 78 South Korea HIV diagnostics market, by mode, 2018 - 2030 (USD Million)
  • Table 79 South Korea HIV diagnostics market by test type, 2018 - 2030 (USD Million)
  • Table 80 South Korea HIV diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 81 Latin America HIV diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 82 Latin America HIV diagnostics market, by mode, 2018 - 2030 (USD Million)
  • Table 83 Latin America HIV diagnostics market by test type, 2018 - 2030 (USD Million)
  • Table 84 Latin America HIV diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 85 Latin America HIV diagnostics market, by region, 2018 - 2030 (USD Million)
  • Table 86 Brazil HIV diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 87 Brazil HIV diagnostics market, by mode, 2018 - 2030 (USD Million)
  • Table 88 Brazil HIV diagnostics market by test type, 2018 - 2030 (USD Million)
  • Table 89 Brazil HIV diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 90 Mexico HIV diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 91 Mexico HIV diagnostics market, by mode, 2018 - 2030 (USD Million)
  • Table 92 Mexico HIV diagnostics market by test type, 2018 - 2030 (USD Million)
  • Table 93 Mexico HIV diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 94 Argentina HIV diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 95 Argentina HIV diagnostics market, by mode, 2018 - 2030 (USD Million)
  • Table 96 Argentina HIV diagnostics market by test type, 2018 - 2030 (USD Million)
  • Table 97 Argentina HIV diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 98 Middle East and Africa HIV diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 99 Middle East and Africa HIV diagnostics market, by mode, 2018 - 2030 (USD Million)
  • Table 100 Middle East and Africa HIV diagnostics market by test type, 2018 - 2030 (USD Million)
  • Table 101 Middle East and Africa HIV diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 102 Middle East and Africa HIV diagnostics market, by region, 2018 - 2030 (USD Million)
  • Table 103 South Africa HIV diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 104 South Africa HIV diagnostics market, by mode, 2018 - 2030 (USD Million)
  • Table 105 South Africa HIV diagnostics market by test type, 2018 - 2030 (USD Million)
  • Table 106 South Africa HIV diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 107 Saudi Arabia HIV diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 108 Saudi Arabia HIV diagnostics market, by mode, 2018 - 2030 (USD Million)
  • Table 109 Saudi Arabia HIV diagnostics market by test type, 2018 - 2030 (USD Million)
  • Table 110 Saudi Arabia HIV diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 111 UAE HIV diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 112 UAE HIV diagnostics market, by mode, 2018 - 2030 (USD Million)
  • Table 113 UAE HIV diagnostics market by test type, 2018 - 2030 (USD Million)
  • Table 114 UAE HIV diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 115 Kuwait HIV diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 116 Kuwait HIV diagnostics market, by mode, 2018 - 2030 (USD Million)
  • Table 117 Kuwait HIV diagnostics market by test type, 2018 - 2030 (USD Million)
  • Table 118 Kuwait HIV diagnostics market, by end-use, 2018 - 2030 (USD Million)

List of Figure

Fig. 1 Market research process

Fig. 2 Data triangulation techniques

Fig. 3 Primary research pattern

Fig. 4 Market research approaches

Fig. 5 Value-chain-based sizing & forecasting

Fig. 6 QFD modeling for market share assessment

Fig. 7 Market formulation & validation

Fig. 8 HIV diagnostics: Market outlook

Fig. 9 HIV diagnostics: Competitive insights

Fig. 10 Parent market outlook

Fig. 11 Related/ancillary market outlook

Fig. 12 Penetration and growth prospect mapping

Fig. 13 Industry value chain analysis

Fig. 14 HIV diagnostics market driver impact

Fig. 15 HIV diagnostics market restraint impact

Fig. 16 HIV diagnostics market strategic initiatives analysis

Fig. 17 HIV diagnostics market: Product movement analysis

Fig. 18 HIV diagnostics market: Product outlook and key takeaways

Fig. 19 Consumables market estimates and forecasts, 2018 - 2030

Fig. 20 Instruments market estimates and forecasts, 2018 - 2030

Fig. 21 Software and services market estimates and forecasts, 2018 - 2030

Fig. 22 HIV diagnostics market: Mode movement analysis

Fig. 23 HIV diagnostics market: Mode outlook and key takeaways

Fig. 24 Self-test market estimates and forecasts, 2018 - 2030

Fig. 25 Lab-based market estimates and forecasts, 2018 - 2030

Fig. 26 HIV diagnostics market: Test type movement analysis

Fig. 27 HIV diagnostics market: Test type outlook and key takeaways

Fig. 28 Antibody test market estimates and forecasts, 2018 - 2030

Fig. 29 Viral load test market estimates and forecasts, 2018 - 2030

Fig. 30 CD4 test market estimates and forecasts, 2018 - 2030

Fig. 31 Other market estimates and forecasts, 2018 - 2030

Fig. 32 HIV diagnostics market: End-use movement analysis

Fig. 33 HIV diagnostics market: End-use outlook and key takeaways

Fig. 34 Diagnostic laboratories market estimates and forecasts, 2018 - 2030

Fig. 35 Hospitals & clinics market estimates and forecasts, 2018 - 2030

Fig. 36 Home settings market estimates and forecasts, 2018 - 2030

Fig. 37 Other market estimates and forecasts, 2018 - 2030

Fig. 38 Global HIV diagnostics market: Regional movement analysis

Fig. 39 Global HIV diagnostics market: Regional outlook and key takeaways

Fig. 40 North America market estimates and forecasts, 2018 - 2030

Fig. 41 U.S. market estimates and forecasts, 2018 - 2030

Fig. 42 Canada market estimates and forecasts, 2018 - 2030

Fig. 43 Europe. market estimates and forecasts, 2018 - 2030

Fig. 44 UK market estimates and forecasts, 2018 - 2030

Fig. 45 Germany market estimates and forecasts, 2018 - 2030

Fig. 46 France market estimates and forecasts, 2018 - 2030

Fig. 47 Italy market estimates and forecasts, 2018 - 2030

Fig. 48 Spain market estimates and forecasts, 2018 - 2030

Fig. 49 Sweden market estimates and forecasts, 2018 - 2030

Fig. 50 Norway market estimates and forecasts, 2018 - 2030

Fig. 51 Denmark market estimates and forecasts, 2018 - 2030

Fig. 52 Asia Pacific market estimates and forecasts, 2018 - 2030

Fig. 53 Japan market estimates and forecasts, 2018 - 2030

Fig. 54 China market estimates and forecasts, 2018 - 2030

Fig. 55 India market estimates and forecasts, 2018 - 2030

Fig. 56 Australia market estimates and forecasts, 2018 - 2030

Fig. 57 Thailand market estimates and forecasts, 2018 - 2030

Fig. 58 South Korea market estimates and forecasts, 2018 - 2030

Fig. 59 Latin America market estimates and forecasts, 2018 - 2030

Fig. 60 Brazil market estimates and forecasts, 2018 - 2030

Fig. 61 Mexico market estimates and forecasts, 2018 - 2030

Fig. 62 Argentina market estimates and forecasts, 2018 - 2030

Fig. 63 Middle East and Africa. market estimates and forecasts, 2018 - 2030

Fig. 64 Saudi Arabia market estimates and forecasts, 2018 - 2030

Fig. 65 South Africa market estimates and forecasts, 2018 - 2030

Fig. 66 UAE market estimates and forecasts, 2018 - 2030

Fig. 67 Kuwait market estimates and forecasts, 2018 - 2030